Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT

Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin r...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2015-06, Vol.40 (6), p.496-498
Main Authors: Arora, Saurabh, Soundararajan, Ramya, Joshi, Prashant, Kumar, Rakesh, Bal, Chandrasekhar
Format: Article
Language:English
Subjects:
Female
Humans
Multimodal Imaging
Neuroendocrine Tumors - diagnostic imaging
Neuroendocrine Tumors - pathology
Organometallic Compounds
Ovarian Neoplasms - diagnostic imaging
Ovarian Neoplasms - secondary
Positron-Emission Tomography
Radiopharmaceuticals
Tomography, X-Ray Computed
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin receptor imaging by Ga-labeled DOTANOC ([1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-Octreotide) PET/CT can be used for localization, staging, and restaging of NET, and it also has an impact on appropriate clinical management of patients with NET. We present here a case of somatostatin receptor expressing bilateral ovarian metastases from NET demonstrated by Ga DOTANOC PET/CT imaging.
ISSN:1536-0229
DOI:10.1097/RLU.0000000000000646